Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients
在乳腺癌患者中,辅助他莫昔芬治疗会降低血浆中信号素4D的水平,而芳香化酶抑制剂治疗则不会。
期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2019.100237
Göbel, Andy; Kuhlmann, Jan D; Link, Theresa; Wimberger, Pauline; Link-Rachner, Cornelia; Thiele, Stefanie; Dell'Endice, Stefania; Furesi, Giulia; Breining, Dorit; Rauner, Martina; Hofbauer, Lorenz C; Rachner, Tilman D